JS Link Inc, formerly DNA Link Inc, is a Korea-based company mainly engaged in the genome analysis business. The Company mainly engages in the research and development of genome analysis services and personal genome analysis service products used for disease prevention, diagnosis, and treatment. The Company also mainly engages in the manufacture and sale of coronavirus disease 2019 (COVID-19) diagnostic kits. In addition, the Company engages in the research and development of â€˜Avatar Mouse,â€™ an anticancer drug efficacy evaluation system using the mouseâ€™s biological system.

Employees

Sector

Biotechnology & Medical Research

More about the company

Quotes

Date	Price	Change	Volume
14/26/14	₩30,100.00	-4.29%	93,584
11/26/11	₩31,450.00	-3.68%	95,238
10/26/10	₩32,650.00	-1.06%	1,57,361
09/26/09	₩33,000.00	+4.10%	1,23,912
08/26/08	₩31,700.00	-2.16%	2,16,410

End-of-day quote Korea S.E.

More quotes

End-of-day quote Korea S.E. 14/09/2026			5-day change	1st Jan Change
30,100.00 ^KRW	-4.29%		-7.10%	+68.63%

14/08	JS Link, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
29/07	JS Link, Inc. announced that it has received KRW 53.392992 billion in funding from Lynas Rare Earths Limited	CI

Market Cap	1,04600Cr 78Cr 67Cr 64Cr 58Cr 108.07Cr 7.44TCr 108.86Cr 758.43Cr 292.25Cr 3.78TCr 291.68Cr 285.25Cr 12TCr	P/E 2024	-10.5x	P/E 2025	-29.7x
Enterprise Value	1,04900Cr 78Cr 67Cr 64Cr 58Cr 108.37Cr 7.46TCr 109.16Cr 760.52Cr 293.06Cr 3.79TCr 292.49Cr 286.04Cr 12TCr	EV / Sales 2024	8.93x	EV / Sales 2025	29.6x
Free-Float	72.31%	Yield 2024 *	-	Yield 2025	-

14/08	JS Link, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
29/07	JS Link, Inc. announced that it has received KRW 53.392992 billion in funding from Lynas Rare Earths Limited	CI
07/07	REalloys Inc. and JS Link Inc. Sign Non-Binding Strategic Letter of Intent to Develop Fully Integrated North American Rare Earth Magnet Platform	CI
07/07	Australia's Lynas, South Korea's JS Link sign deal for Malaysia magnet factory	RE
07/07	Australia's Lynas signs deal with South Korea's JS Link to develop Malaysian magnet factory	RE
25/06	JS Link, Inc. announced that it has received KRW 30 billion in funding from Joosung Sea & Air Co. Ltd	CI
15/05	JS Link, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
13/05	JS Link, Inc. announced that it expects to receive KRW 5 billion in funding	CI
13/05	JS Link, Inc. announced that it expects to receive KRW 30 billion in funding	CI
23/03	JS Link, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03/02	JS Link, Inc. announced that it has received KRW 20.00000805 billion in funding from Orbitech Co., Ltd., Joosung Sea & Air Co. Ltd	CI
14/11	JS Link, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
03/11	Malaysia PM says $142 million magnet plant to boost rare earth sector, state media reports	RE

1 day	-4.29%
1 week	-7.10%
Current month	-8.79%
1 month	-25.68%
3 months	-8.65%
6 months	-28.16%
Current year	+68.63%

JS Link, Inc. Share Price

Stocks

A127120

KR7127120004

Biotechnology & Medical Research

Valuation: JS Link, Inc.

Chart: JS Link, Inc.

Latest news: JS Link, Inc.

Press Releases: JS Link, Inc.

Quotes and Performance

Price Extremes

Managers and Directors: JS Link, Inc.

Latest insider transactions

Other Biotechnology & Medical Research

Financials

Company Profile

Quotes

1 week	29,950	33,250
1 month	29,300	41,400
Current year	16,230	49,900
1 year	13,860	49,900
3 years	1,775	49,900
5 years	1,775	49,900
10 years	1,775	49,900

Manager	Title	Age	Since
Jun-Young Lee CEO	Chief Executive Officer	58	23/08/2024
Cheol-Gu Sim CEO	Chief Executive Officer	47	20/10/2023
Kenji Gonishi PRN	Corporate Officer/Principal	58	23/08/2024

Director	Title	Age	Since
Cheol-Gu Sim BRD	Director/Board Member	47	20/10/2023
Jun-Young Lee BRD	Director/Board Member	58	23/08/2024
Kenji Gonishi BRD	Director/Board Member	58	23/08/2024

Date	Insider	Type	Quantity	% Market Cap.
19/11/25	Jin-soo Park	Buy	1,500	0.0047%
17/11/25	Jin-soo Park	Buy	5,000	0.0157%
04/11/25	Jin-soo Park	Buy	87,138	0.2742%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
JS LINK, INC.	-4.29%	-7.10%	+73.29%	+730.34%	78Cr
LONZA GROUP AG	-0.62%	-4.42%	-2.89%	+6.84%	4.56TCr
REVOLUTION MEDICINES, INC.	+0.66%	-2.34%	+340.62%	+530.14%	4.4TCr
IQVIA HOLDINGS INC.	+1.49%	-0.78%	+41.90%	+24.75%	4.37TCr
BEONE MEDICINES AG	+2.11%	-1.24%	+9.09%	+78.25%	4.02TCr
CELLTRION, INC.	+0.34%	-4.03%	+9.34%	+38.90%	3.19TCr
ASCENDIS PHARMA A/S	+0.53%	-2.08%	-	-	1.74TCr
MEDPACE HOLDINGS, INC.	+1.34%	+0.70%	+21.35%	+112.62%	1.66TCr
EUROFINS SCIENTIFIC SE	+0.44%	+1.85%	+14.97%	+31.00%	1.45TCr
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1.85%	-5.33%	+78.63%	+31.45%	1.3TCr
Average	+0.03%	-2.06%	+65.15%	+176.03%	2.68TCr
Weighted average by Cap.	+0.66%	-2.02%	+75.88%	+129.38%

	2024	2025
Net sales	1.59TCr 1.18Cr 1.02Cr 96.57L 87.61L 1.64Cr 113.19Cr 1.66Cr 12Cr 4.44Cr 57Cr 4.44Cr 4.34Cr 182.56Cr	1.93TCr 1.43Cr 1.24Cr 1.17Cr 1.06Cr 2Cr 137.45Cr 2.01Cr 14Cr 5.4Cr 70Cr 5.39Cr 5.27Cr 221.68Cr
Net income	-1.08TCr -80.19L -69.49L -65.58L -59.49L -1.12Cr -77Cr -1.12Cr -7.83Cr -3.02Cr -39Cr -3.01Cr -2.95Cr -123.96Cr	-1.64TCr -1.22Cr -1.06Cr -99.84L -90.57L -1.7Cr -117.02Cr -1.71Cr -12Cr -4.59Cr -59Cr -4.59Cr -4.48Cr -188.73Cr
Net Debt	1.44TCr 1.07Cr 92.59L 87.37L 79.27L 1.49Cr 102.41Cr 1.5Cr 10Cr 4.02Cr 52Cr 4.01Cr 3.92Cr 165.17Cr	288.15Cr 21.39L 18.54L 17.49L 15.87L 29.77L 21Cr 29.99L 2.09Cr 80.5L 10Cr 80.35L 78.58L 33Cr